Strategic BD Director, Patient-Centered Solutions

IQVIA Inc; Madrid; On-site; EUR 90,000 - 150,000; Full time

Job summary

IQVIA Inc is seeking an experienced Director of Business Development for Cronos Patient-Centered Solutions. This client-facing, strategic sales role focuses on creating new business, expanding key accounts, and building senior-level client relationships across biopharma and CROs.

You will lead opportunity strategy, coordinate cross-functional experts, and drive commercial success in a fast-evolving market. Travel up to 30% and comfort with complex clinical development challenges are required.

Qualifications

• Proven success in business development, enterprise sales, or strategic growth in life sciences or healthcare technology.
• Ability to originate and advance net-new opportunities, including pre-RFP scenarios.
• Demonstrated skill in building senior-level client relationships across complex organizations.

Responsibilities

• Own development of new business and achieve sales targets across defined geographies or markets.
• Build pipeline by originating and progressing net-new opportunities.
• Develop relationships within pharma, biotech, and CROs where Cronos has limited presence.
• Expand relationships within existing strategic accounts by identifying new stakeholders and programs.
• Lead client conversations, align needs with Cronos, IQVIA, and partner capabilities.
• Maintain CRM data and forecast information with accuracy.

Skills

Enterprise sales

Strategic account growth

Complex solutions selling

Stakeholder management

Negotiation

Life sciences knowledge

Job description

IQVIA Inc is seeking an experienced Director of Business Development for Cronos Patient-Centered Solutions. This client-facing, strategic sales role focuses on creating new business, expanding key accounts, and building senior-level client relationships across biopharma and CROs.

You will lead opportunity strategy, coordinate cross-functional experts, and drive commercial success in a fast-evolving market. Travel up to 30% and comfort with complex clinical development challenges are required.